 The Company will host a conference call and webcast at 4:30 p.m. ET that day to review the results. Participants may also listen to a live webcast of the call through the Events and Presentations section under Investor Relations on Misonixs website at Misonix, Inc. MSON designs, manufactures and markets minimally invasive ultrasonic medical devices used for precise bone sculpting, removal of soft and hard tumors and tissue debridement, primarily in the areas of neurosurgery, orthopedic surgery, plastic surgery, wound care and maxillo-facial surgery. 